1. Ferroptosis in Carcinoma: Regulatory Mechanisms and New Method for Cancer Therapy
- Author
-
Shi ZZ, Fan ZW, Chen YX, Xie XF, Jiang W, Wang WJ, Qiu YT, and Bai J
- Subjects
autophagy ,iron ,cancer ,p53 ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 ,ferroptosis - Abstract
Zhi-Zhou Shi,1,* Ze-Wen Fan,1,* Yun-Xia Chen,1 Xiu-Feng Xie,1 Wen Jiang,2 Wen-Jun Wang,1 Yun-Tan Qiu,1 Jie Bai1 1Medical School, Kunming University of Science and Technology, Kunming, People’s Republic of China; 2Department of Thoracic Surgery, The First People’s Hospital of Yunnan Province, Kunming, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zhi-Zhou Shi; Jie BaiMedical School, Kunming University of Science and Technology, No. 727 Jingming South Road, Kunming 650500, People’s Republic of ChinaEmail zhizhoushi@126.com; jiebai662001@126.comAbstract: Ferroptosis is a new form of programmed cell death with characteristic accumulation of reactive oxygen species (ROS) resulting from iron accumulation and lipid peroxidation. Ferroptosis is involved in many diseases, including cancer, and induction of ferroptosis has shown attractive antitumour activities. In this review, we summarize recent findings on the regulatory mechanisms of key regulators of ferroptosis, including the catalytic subunit solute carrier family 7 member 11 (SLC7A11), the glutathione peroxidase 4 (GPX4), p53 and non-coding RNAs, the correlations between ferroptosis and iron homeostasis or autophagy, ferroptosis-inducing agents and nanomaterials and the diagnostic and prognostic value of ferroptosis-associated genes in TCGA data.Keywords: ferroptosis, cancer, iron, autophagy, p53
- Published
- 2019